Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Boswellic acid, a group of pentacyclic triterpenic acids derived from the resin of Boswellia species (frankincense), has been investigated for its anti-inflammatory properties, which indirectly support the skeletal system. Several studies have shown that boswellic acids inhibit 5-lipoxygenase, an enzyme involved in the synthesis of leukotrienes that contribute to inflammation. This mechanism is relevant to bone and joint health, particularly in conditions like osteoarthritis and rheumatoid arthritis. Clinical trials, including randomized controlled studies, have found that Boswellia extracts can reduce pain and improve function in osteoarthritis patients, with some evidence of improved joint mobility and decreased swelling.

However, while these benefits primarily relate to the joints, there is limited direct evidence that boswellic acids enhance bone density or directly improve bone tissue health. The main scientific support lies in the compound's ability to reduce inflammation and joint degradation, indirectly benefiting the skeletal system by alleviating symptoms of degenerative bone diseases. Reviews and meta-analyses generally acknowledge the anti-inflammatory and analgesic effects of Boswellia, but call for more rigorous, long-term studies to assess its effects on bone tissue directly. In summary, boswellic acid's use to support the skeletal system is scientifically grounded, mostly through its anti-inflammatory action in joint-related conditions, though evidence for direct bone-strengthening effects is currently limited.

More about Boswellic Acid
More about Skeletal System (Bones)

Other ingredients that support Skeletal System (Bones)

Other body systems supported by Boswellic Acid

Products containing Boswellic Acid